Several lung conditions produce symptoms, breathing-test results, or imaging findings so similar to emphysema that even experienced clinicians mix them up. Chronic asthma with fixed airflow obstruction, rare cystic lung diseases, airway collapse syndromes, and vascular disorders can all look like emphysema on a chest scan or a pulmonary function test. The overlap matters because the treatments differ, and a wrong label can mean years of ineffective therapy.
Misdiagnosis Is Surprisingly Common
Before diving into specific look-alikes, it helps to know how often emphysema and its parent diagnosis, COPD, get pinned on the wrong patient. A mixed-methods study exploring COPD misdiagnosis in primary care found that roughly 59 percent of patients had been misdiagnosed with COPD, largely because their spirometry reports were difficult to interpret, and another 18 percent were misdiagnosed because spirometry was never performed at all. Among 99 patients whose underlying diagnosis was later investigated, about 41 percent had completely normal lung function and 40 percent actually had asthma.1PLoS One. Exploring the causes of COPD misdiagnosis in primary care: A mixed methods study These numbers suggest that the problem is not just about rare diseases sneaking in under the radar. Ordinary conditions, especially asthma, account for a huge share of the confusion.
Chronic Asthma with Fixed Airflow Obstruction
Emphysema destroys the tiny air sacs in the lungs, which makes them lose their elastic recoil and traps air inside. Long-standing asthma can produce something that looks almost identical on a breathing test: fixed obstruction that does not reverse with a bronchodilator, plus hyperinflation at every lung volume. A study of 18 adults with chronic persistent asthma and fixed obstruction found that all of them had markedly abnormal airflow curves and hyperinflation at residual volume, functional residual capacity, and total lung capacity. Yet their diffusing capacity was normal or even elevated, and their lung CT scans showed no structural damage.2PubMed. Unsuspected pseudophysiologic emphysema in chronic persistent asthma The researchers called this “pseudophysiologic emphysema” because the physiology mimicked emphysema perfectly while the lungs themselves were structurally intact.
The distinction matters for treatment. Emphysema management focuses on slowing further destruction and managing air trapping, while asthma management centers on controlling airway inflammation and bronchoconstriction. A patient who carries an emphysema label when asthma is the true culprit may miss out on inhaled corticosteroids or biologic therapies that could meaningfully improve their breathing. The key differentiator in this scenario is the diffusing capacity test and a high-resolution CT scan. If both are normal, the odds tilt heavily toward asthma, even when the flow-volume curves look terrible.
Tracheobronchomalacia
Tracheobronchomalacia, or TBM, occurs when the walls of the windpipe or large bronchial tubes are abnormally floppy. During exhalation, these weakened airways collapse inward, restricting airflow in a way that can feel exactly like the airflow limitation of emphysema. Patients typically present with chronic cough, shortness of breath, and difficulty clearing secretions. Because the symptoms and even some of the test results overlap with COPD, asthma, and bronchiectasis, TBM is frequently misdiagnosed and treated with medications that do little good.3PubMed Central. Severe tracheobronchomalacia misdiagnosed as an asthma exacerbation
A standard chest CT taken during a held breath may look entirely unremarkable. The collapse only shows itself on dynamic imaging, such as a CT or bronchoscopy performed while the patient exhales forcefully. Because this step is not routine, some patients bounce between inhalers and emergency visits for years before someone orders the right study. Treatment, when the diagnosis is finally made, can include airway stenting or surgical reinforcement, which are approaches that have no parallel in emphysema care.
Vocal Cord Dysfunction
While TBM involves collapse of the lower airways, a similar obstruction problem can originate higher up. Vocal cord dysfunction occurs when the vocal folds close inappropriately during breathing, usually during inhalation, creating a choking or wheezing sensation that clinicians frequently mistake for obstructive lung disease. A study of 71 hospitalized patients admitted for asthma or COPD exacerbations found vocal cord dysfunction in 28 percent of the overall group. Among COPD patients specifically, the rate was even higher, at about 38 percent, and those with severe or very severe chronic COPD were most likely to have it.4European Respiratory Journal. Vocal cord dysfunction (VCD) in hospitalised exacerbations of asthma and chronic obstructive pulmonary disease (COPD)
In some patients, vocal cord dysfunction coexists with true emphysema, making each condition harder to detect. In others, it is the sole cause of symptoms that have been attributed to emphysema for years. The diagnosis usually requires laryngoscopy during an episode of symptoms. If you have been told you have emphysema but your breathing tests fluctuate wildly from visit to visit or your symptoms do not respond to standard COPD medications, vocal cord dysfunction is worth investigating.
Cystic Lung Diseases on Imaging
Emphysema shows up on a CT scan as areas of abnormally low density, often with visible destruction of lung tissue. Several cystic lung diseases create holes or cyst-filled patterns that can look disturbingly similar, especially on a quick read.
Lymphangioleiomyomatosis
Lymphangioleiomyomatosis, usually called LAM, is a rare disease that primarily affects women of reproductive age. It causes smooth-muscle-like cells to proliferate in the lungs, creating thin-walled cysts scattered throughout both lung fields. A study of 45 LAM patients found that emphysema-like changes in the non-cystic areas of the lung were present in 31 of them.5AJR Am J Roentgenol. CT grading of lung disease in lymphangioleiomyomatosis That overlap complicates interpretation. The cysts of LAM tend to be round, thin-walled, and uniformly distributed, which can help distinguish them from the irregular areas of destruction seen in centrilobular emphysema. But when emphysema-like changes surround the cysts, even experienced radiologists may hesitate.
Pulmonary Langerhans Cell Histiocytosis
This condition, which occurs almost exclusively in young smokers, goes through a sequence of changes on imaging. Early on, small nodules dot the upper and middle lung zones. As the disease progresses, those nodules cavitate and evolve into cysts that vary in size but are mostly under a centimeter in diameter. These cysts can be isolated or confluent, and when they cluster together, they sometimes mimic the appearance of centrilobular emphysema.6European Respiratory Journal. Adult pulmonary Langerhans’ cell histiocytosis Because both conditions are linked to smoking, they can even coexist, which makes sorting one from the other a genuine challenge. The upper-zone dominance and the presence of nodules alongside cysts are helpful clues, but the overlap is real.
Birt-Hogg-Dubé Syndrome
Birt-Hogg-Dubé syndrome, or BHD, is a genetic condition caused by mutations in the folliculin gene. It can cause skin bumps, kidney tumors, and, most relevant here, multiple lung cysts. The pulmonary cysts of BHD tend to cluster in the lower lung zones and along the lung’s surfaces, and they often sit near or wrap around blood vessels. Because the condition is underrecognized, patients are frequently mislabeled as having COPD, emphysema, or ordinary blebs.7PubMed Central. Pulmonary manifestations of Birt-Hogg-Dubé syndrome
The main clue is the location and shape of the cysts. Emphysema tends to affect the upper lobes, at least in smokers, and creates irregular areas of tissue loss. BHD cysts favor the lower and middle lung fields, often have an elliptical or lentiform shape, and cluster in the subpleural and perivascular regions.8European Respiratory Review. Birt–Hogg–Dubé syndrome A history of recurrent pneumothorax, especially in a non-smoker or someone younger than expected for emphysema, should raise suspicion.9Polish Journal of Radiology. Familial pneumothoraces – Birt-Hogg-Dubé syndrome. Differentiation with other cystic lung diseases Genetic testing confirms the diagnosis and opens the door to surveillance for kidney tumors, which is arguably the most important downstream consequence of getting this right.
Constrictive Bronchiolitis
Constrictive bronchiolitis is a scarring process that narrows or obliterates the smallest airways in the lungs. Unlike emphysema, it does not destroy the air sacs themselves. The damage is limited to the bronchioles, but the downstream effect is severe air trapping. Chest CT typically shows a mosaic pattern of alternating light and dark areas, and air trapping becomes obvious on images taken during exhalation.10PubMed. Constrictive bronchiolitis obliterans: the fibrotic airway disorder The mosaic pattern can superficially resemble the patchy destruction of panlobular emphysema, and breathing tests show obstruction that often looks indistinguishable from COPD.
The condition arises from a variety of triggers. Lung or bone-marrow transplant recipients are at particular risk, but it can also follow viral infections, toxic fume exposure, or autoimmune conditions. Treatment focuses on the underlying cause and on suppressing the fibrotic process, which is a fundamentally different strategy from emphysema management.
Swyer-James-MacLeod Syndrome
This rare condition is a specific form of post-infectious constrictive bronchiolitis that usually results from a severe childhood lung infection. It typically affects one lung or one lobe, producing unilateral hyperlucency on a chest X-ray: one side of the chest looks abnormally dark. Because emphysema can also appear asymmetric, the two conditions overlap on plain films. Swyer-James-MacLeod syndrome involves constrictive bronchiolitis combined with dilation and destruction of the air sacs and reduced blood flow to the affected lung, which traps air and keeps the lung from expanding normally.11Radiology Case Reports. Swyer-James-MacLeod syndrome presenting as spontaneous pneumothorax in an adult: Case report and review of literature
The classic giveaway is asymmetry. Emphysema caused by smoking tends to affect both lungs, whereas Swyer-James usually presents in a single lung with diminished pulmonary vessels on that side. The history often includes severe respiratory infections in childhood. Because the affected lung never fully developed, its capacity is reduced from the start, and the patient may have adapted to a degree that masks the severity on routine testing.
Chronic Thromboembolic Pulmonary Hypertension
Chronic thromboembolic pulmonary hypertension, or CTEPH, develops when blood clots in the lungs fail to dissolve and instead organize into scar tissue that permanently blocks pulmonary arteries. The resulting uneven blood flow creates a mosaic attenuation pattern on CT. Darker patches correspond to poorly perfused regions with shrunken blood vessels, while brighter patches represent areas where blood has been rerouted in excess.12American Journal of Case Reports. Chronic Thromboembolic Pulmonary Hypertension: Do not Miss the Chance for an Early Diagnosis
At a glance, those dark patches can look like the areas of tissue destruction seen in emphysema. The distinction matters enormously: CTEPH is one of the few forms of pulmonary hypertension that can be cured with surgery. If the mosaic pattern is mistakenly attributed to emphysema, the patient may never receive the specialized workup that includes ventilation-perfusion scanning and pulmonary angiography. The clue is that the dark patches in CTEPH do not represent destroyed tissue, as they do in emphysema. They represent tissue that is intact but starved of blood flow. Looking at vessel size within those patches can help: in CTEPH the vessels are smaller in the dark areas, while in emphysema the tissue is simply gone.
Giant Bullae and Vanishing Lung Syndrome
Giant bullae are large air-filled spaces that form in the lung, sometimes expanding to fill most of the chest cavity. Vanishing lung syndrome is a dramatic version of this in which progressive bullae compress the remaining functional lung tissue. On a chest X-ray, a giant bulla can look indistinguishable from a pneumothorax, with a large dark space and a visible lung edge. One case report described a 64-year-old man with frequent COPD hospitalizations who was found to have giant bullae mimicking a pneumothorax on initial imaging.13PubMed Central. Vanishing Lung Syndrome: An Idiopathic Bullous Emphysema Mimicking Pneumothorax The distinction between giant bullae and widespread emphysema is not just academic. A patient with a dominant giant bulla compressing otherwise healthy lung tissue may be a candidate for bullectomy, a surgery that can dramatically improve breathing. If the bullae are simply lumped in with generalized emphysema, that surgical option may never be offered.
Giant bullae can develop in smokers, in patients with alpha-1 antitrypsin deficiency, or even without an identifiable cause. They are most common in the upper lobes. A CT scan makes the diagnosis straightforward in most cases, but on a plain chest X-ray, the confusion with pneumothorax or simple emphysema is a real pitfall, especially in emergency settings where a quick decision is needed.
Why CT Thresholds Are Not as Clear-Cut as They Seem
Doctors and researchers often define emphysema on CT using density thresholds. If a voxel of lung tissue falls below a certain Hounsfield unit value, it gets counted as emphysematous. A study establishing normal ranges in young men set the upper limit of normal for emphysema at about 2.7 percent of lung voxels below –950 Hounsfield units on inspiratory CT.14AJR Am J Roentgenol. Normal range of emphysema and air trapping on CT in young men That threshold sounds precise, but it is a moving target. Different scanners, reconstruction algorithms, and even the depth of the patient’s breath can shift the numbers. Air trapping from any cause, whether it is constrictive bronchiolitis, asthma, or TBM, can push density values below the cutoff and be counted as emphysema by quantitative software.
This is one reason why an automated CT readout that says “mild emphysema” should not be accepted uncritically. The measurement is only as good as the clinical context around it. If a 35-year-old non-smoker with a history of childhood pneumonia shows a few percent of low-attenuation voxels on CT, the likely explanation is post-infectious air trapping, not emphysema. The numbers on the report do not make the diagnosis. The clinician reading them in context does.
When to Push for a Second Look
If you have been diagnosed with emphysema but something feels off, there are a few scenarios worth bringing up with your doctor. Patients who have never smoked, or who smoked only lightly, deserve extra scrutiny. Emphysema is overwhelmingly associated with tobacco smoke or occupational exposures, so a diagnosis in a non-smoker should prompt a search for other causes, particularly genetic conditions like BHD or alpha-1 antitrypsin deficiency, or post-infectious syndromes like Swyer-James.
An emphysema diagnosis in someone under 45 also warrants a closer look. While early-onset emphysema can happen, particularly with alpha-1 antitrypsin deficiency, the differential diagnosis at that age broadens to include LAM in women, Langerhans cell histiocytosis in smokers, and BHD in patients with a family history of pneumothorax or kidney tumors. Similarly, if your symptoms swing wildly from day to day, respond dramatically to certain triggers, or do not improve at all with standard COPD inhalers, the underlying condition may not be emphysema. Vocal cord dysfunction and tracheobronchomalacia both produce symptoms that fluctuate more than typical emphysema, and asthma masquerading as COPD responds to different medications.
Imaging location is another red flag. Emphysema from smoking typically hits the upper lobes hardest. If your CT report notes that the abnormalities are concentrated in the lower lobes or are strikingly one-sided, the pattern is more consistent with BHD, Swyer-James syndrome, or alpha-1 antitrypsin deficiency. Requesting a review by a pulmonologist or thoracic radiologist who sees these patterns regularly can make the difference between a decade of wrong treatment and a precise diagnosis.